1991P Subgroup analyses of patients (pts) with advanced urothelial carcinoma (aUC) who had long-term progression-free survival (PFS) or overall survival (OS) with avelumab first-line maintenance (1LM) in the AVENANCE real-world study
| Autor: | Barthelemy, P., Eymard, J-C., Flechon, A., Gross Goupil, M., Voog, E., Loriot, Y., Abraham Jaillon, C., Gobert, A., Chasseray, M., Kazan, E., Josse, C., Lambert, P., Paret, L., Thibault, C. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1151-S1152 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|